Latest Indo–German Collaboration Progress Meeting – 21 February 2026, AIIMS Delhi (Dr. M. D. Ray)

The Indo–German collaboration on artificial intelligence and robotic surgery represents a major step forward in global healthcare innovation. On 25 July 2025, a Memorandum of Understanding (MoU) was signed between AIIMS Delhi and TU Dresden, Germany, establishing a framework for advancing AI-enabled precision surgery under the leadership of AIIMS Delhi.

The collaboration is guided by Prof. Srinivas, Director of AIIMS Delhi, with Prof. Dr. M. D. Ray, Senior Surgical Oncologist at AIIMS, playing a leading role in developing the Robotic Oncology Surgery program. An interim progress review meeting was held on 21 February 2026 in New Delhi, where participating teams assessed initial achievements and defined priorities for the next phase of the project.

Advancing Robotic Oncology and AI-Driven Surgery

The collaboration focuses on three key areas of innovation:

1. Robotic Oncology Surgery
The program aims to design cost-effective and scalable robotic surgical systems specifically suited for cancer treatment. The objective is to expand access to high-precision robotic oncology procedures, particularly in resource-constrained healthcare settings.

2. Artificial Intelligence in Surgical Oncology
Advanced AI technologies are being integrated into surgical workflows to improve tumor identification, enhance surgical accuracy, reduce procedural risks, and support real-time clinical decision-making.

3. Liquid Biopsy for Early Cancer Detection
Another important research focus is the development of non-invasive liquid biopsy techniques. These blood-based diagnostic tools are intended to enable earlier cancer detection and more effective disease monitoring, potentially transforming cancer diagnosis and management.

This Indo–German partnership represents an important step toward making advanced surgical technologies more precise, accessible, and affordable for patients worldwide.